Following continued tailwinds in private markets, and larger contract values coinciding with elongated due diligence timelines, SS&C?s Alternatives and Intralinks businesses about grew about 7% and 11%, respectively, in fiscal 2023. This supported about 3% organic growth in the overall business during the year, partially offset by declines in its Institutional and Investment Management (I&IM) and Healthcare segments owing to tough comps on the previous year's performance. Profitability improved as well over the year, with EBITDA margins near 35% driven by SS&C?s digital worker initiative, which is expected to yield nearly $100 million in cost savings annually. Strong free operating cash flow (FOCF) generation of about $1 billion prompted further value distribution to shareholders, and the company repurchased about $480
